Affidea Scientific Talks :: Challenges in Prostate Cancer: Screening and early Diagnosis - Affidea Portugal

Affidea Scientific Talks :: Challenges in Prostate Cancer: Screening and early Diagnosis

Webinar | 20th October 2022 
6pm EEST/5pmCET/4pmWET

The webinar “Challenges in Prostate Cancer: Screening and early Diagnosis” is an overview of current clinical considerations on prostate cancer screening and early diagnosis, mpMRI and minimal invasive procedures for prostate cancer detection and treatment.

 

tracejado

Scientific Programme 

(time zone EEST)

06.00 pm – Clinical considerations on prostate cancer screening and early diagnosis :: Dr Aušvydas Patašius

06.20 pm – Current and future role of multiparametric MRI (mpMRI) :: Dr Rūta Grigienė

06.35 pm – Minimal invasive procedures for prostate cancer diagnosis and treatment :: Dr Mantas Trakymas

06.50 pm – Q&A

07.00 pm – Closing remarks

 

Click here to learn more about the program and objectives.

 

tracejado

Scientific Support

Lithuanian Soc Oncology

 

tracejado

 

Target Audience

The webinar is organized for radiologists, urologists, radiation oncologists and other medical specialists with interest in prostate cancer.

 

tracejado

Registration

Registration is mandatory and free of charge.
Register here!

 

tracejado

Organizing Committee

Dr. Rūta Grigienė, Chair of the webinar, Affidea Lithuania
Dr. Rosana Santos, Clinical Education Scientific Leader, Affidea Group

 

tracejado

Invited Speakers

 

prostate webinar_speakers

 

Dr. Aušvydas Patašius, MD, PHD, urologist, Department of Oncology, National Cancer Institute, Vilnius, Lithuania

Dr. Mantas Trakymas, MD PHD, Interventional radiologist, Department of Diagnostic and Interventional Radiology, Chief of interventional radiology, National Cancer Institute, Vilnius, Lithuania

Dr. Rūta Grigienė, MD PHD, consultant radiologist, Affidea Lithuania; GU/Prostate Imaging Subspecialty Leader at Affidea; consultant radiologist, Department of Diagnostic and Interventional Radiology,  National Cancer Institute, Vilnius, Lithuania